| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3996508 | Practical Radiation Oncology | 2016 | 8 Pages |
Abstract
There is extreme variation in physician recommendations regarding prophylactic corticosteroid and anticonvulsant use for patients undergoing SRS. Further investigation of the risks and benefits of these medications for SRS is warranted, which may promote guideline development and more patient-centered, rational prescribing practices.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Nils D. MD, Nancy E. BA, Anand MD, Sheila RN, BSN, OCN, Rachel RN, BSN, OCN, Stephanie E. MD, Paul J. MB, FFR, RCSI, Brian M. MD, MPH,